Release Date: 05/12/17 17:59 Summary: On Market Takeover Bid Price Sensitive: Yes Download Document 292.2KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%